예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>글로벌 원격 환자 모니터링 및 치료 시장, 기기 유형별(심장 모니터링 기기, 혈압 모니터링 기기, 혈당 모니터링 기기, 호흡 모니터링 기기, 신경 모니터링 기기, 다중 매개변수 모니터링 기기 및 기타), 응용 분야별(종양학, 당뇨병, 심혈관 질환 및 기타), 최종 사용자(병원 기반 환자, 외래 환자 및 재택 의료 환자) - 업계 동향 및 2030년까지의 예측.
원격 환자 모니터링 및 케어 시장 분석 및 통찰력
RPM과 케어 접근 방식은 최근 몇 년 동안 점점 더 인기를 얻고 있으며, 특히 COVID-19 팬데믹으로 인해 원격 케어 옵션에 대한 수요가 증가했습니다. 전 세계적으로 RPM과 케어에 대한 인식이 높아짐에 따라 시장 수요가 증가했습니다. 더 나은 건강 서비스를 위한 의료 지출 증가도 시장 성장에 기여합니다. 주요 시장 참여자는 이 중요한 기간 동안 다양한 서비스 출시와 승인에 집중합니다. 또한 장치의 향상된 기술 발전도 RPM과 케어에 대한 수요 증가에 기여합니다.
글로벌 원격 환자 모니터링 및 케어 시장은 시장 참여자의 증가와 고급 원격 모니터링 장치의 가용성으로 인해 예측 연도에 성장할 것으로 예상됩니다. 이와 함께 제조업체는 시장에 새로운 장치와 효율적이고 정확한 RPM 제품을 출시하기 위한 개발 활동에 참여하고 있습니다. 고급 의료 기술 분야의 개발이 증가함에 따라 시장 성장이 더욱 촉진되고 있습니다. 그러나 RPM 및 케어 제품의 생산 및 상용화에 대한 엄격한 규정과 같은 어려움으로 인해 예측 기간 동안 시장 성장이 제한될 것으로 예상됩니다.
진보와 개발에 대한 의료 지출 증가는 시장 성장의 기회를 제공할 것으로 예상됩니다. 그러나 원격 모니터링 및 케어 장치의 높은 비용은 시장 성장에 도전이 될 것으로 예상됩니다.
다양한 회사가 점진적으로 시장 성장을 이루는 이니셔티브를 취하고 있습니다.
예를 들어,
- 2023년 1월 CoachCare는 윈스턴-세일럼에 본사를 둔 RPM 회사 NVOLVE를 인수하여 통증, 척추 및 정형외과 분야에서 RPM 전문성을 확장한다고 발표했습니다. 이 인수는 회사의 제품 포트폴리오와 사업 확장에 도움이 될 것입니다.
Data Bridge Market Research에 따르면, 글로벌 원격 환자 모니터링 및 치료 시장은 2030년까지 25,769.22백만 달러 규모에 도달할 것으로 예상되며, 2023~2030년 예측 기간 동안 연평균 성장률은 12.5%입니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 해 |
2021 (2015~2020년까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital-Based Patients, Ambulatory Patients, and Home Healthcare Patients) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa |
|
Market Players Covered |
Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips N.V., OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, and Withings among others |
Market Definition
Remote Patient Monitoring (RPM) and care is a healthcare delivery model that allows healthcare providers to monitor patients remotely, using various technological devices and communication tools, without the need for face-to-face visits. This approach enables healthcare providers to deliver care and track patient health data from a distance, often in real time.
RPM typically involves the use of sensors-enabled wearable devices and other technological devices that can track a patient's vital signs, medication adherence, physical activity, and other health-related information. The collected data is then transmitted to healthcare providers who can analyze the information and take appropriate action, such as adjusting medication dosages, providing guidance on lifestyle changes, or scheduling follow-up appointments.
Global Remote Patient Monitoring and Care Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Increasing Prevalence of Chronic Diseases
The market is expanding due to various causes, including the increasing prevalence of chronic diseases. Chronic diseases are non-communicable illnesses that last long and necessitate continuing medical care and management.
According to the World Health Organization, chronic diseases account for nearly 70% of all deaths worldwide, with cardiovascular disease being the primary cause. The rising prevalence of chronic diseases is increasing due to many variables, including an aging population, sedentary lifestyles, poor nutrition, and environmental factors. RPM and care can help healthcare providers to manage chronic diseases more efficiently and effectively.
As a result of the sedentary lifestyle of people, the prevalence of lifestyle-associated disorders such as hypertension and diabetes witnessed a rise. Thus, the rising prevalence of chronic diseases with the growing integration of healthcare data with portable devices is expected to demand proper health management, leading to the anticipated increasing demand for RPM and care in the market in the forecast period.
Restraint
- Strict Regulatory Framework
Regulatory bodies play a critical role in ensuring that remote patient monitoring technologies meet safety and quality standards and protect patient privacy. However, regulatory compliance can be a significant barrier to entry for many companies and may slow down the adoption of remote patient monitoring technologies.
The medical device regulations hold significant responsibility for safeguarding the health of the people in the medical device industry itself. The regulations require manufacturers to inculcate quality systems (based on internationally accepted standards for quality systems) into the design process for class III and IV devices. They also require manufacturers to incorporate them into the manufacturing process for class II, III, and IV devices.
Along with such strict regulations of medical devices, it has also been reported that Health Canada’s decision related to medical device applications is not timely. It involves reviewing the submission of scientific evidence by manufacturers to ensure the efficacy of various devices.
This suggests that such a tedious procedure led to the development of other technologically advanced devices and hence, poses a big challenge in front of device manufacturers in submitting the approval documentation.
The regulations imposed would delay the supply of the instrumentation and long-time approval for the devices. This factor is expected to act as a restraint for market growth.
Opportunity
-
Strategic Initiatives by Market Players
The strategic initiatives taken by the key market players have helped in the rise in technologies and advancements in remote patient monitoring products and devices. They are taking initiatives such as product launches, collaborations, mergers, and acquisitions among others, which is expected to create more opportunities for market growth.
Healthcare product suppliers have a huge opportunity to work with new technology firms to ensure the industry's continued growth, creativity, and viability.
To discover and develop advanced remote monitoring facilities, companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.
These strategic initiatives such as product launches, approvals, acquisitions, and mergers done by major companies in the market have opened up an opportunity for companies in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is expected to provide an opportunity for market growth.
Challenge
- Lack of Skilled Professionals
Remote patient monitoring requires a range of professionals with specialized knowledge and expertise, including clinicians, technicians, and data analysts.
Clinicians are responsible for monitoring patient's health remotely and interpreting the data collected by remote patient monitoring devices.
Moreover, technicians are responsible for installing, maintaining, and troubleshooting remote patient monitoring devices. Data analysts are responsible for analyzing the data collected by remote patient monitoring devices and providing insights to healthcare providers. However, there is currently a shortage of data analysts, clinicians, and technicians with the necessary skills and experience to provide meaningful insights from remote patient monitoring data.
The lack of skilled professionals can also limit the adoption of RPM technologies and limit their potential to improve healthcare outcomes. Without skilled professionals, healthcare providers may struggle to interpret patient data and provide appropriate interventions, limiting the effectiveness of RPM in improving patient outcomes. Thus, the lack of skilled professionals is a significant factor expected to pose a challenge to market growth.
Recent Developments
- In January 2023, Masimo and Philips announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. This collaboration extension would help the company in remote patient monitoring product portfolio expansion.
- In December 2022, Masimo announced the full market release of the Hydration Index (Hi) for the Masimo W1 watch. The Masimo W1, an advanced health-tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful health data, from the leader in hospital pulse oximetry. This product upgradation would help the company in product business expansion.
Global Remote Patient Monitoring and Care Market Scope
The global remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Device Type
- Cardiac Monitoring Devices
- Blood Pressure Monitoring Devices
- Blood Glucose Monitoring Devices
- Respiratory Monitoring Devices
- Neurologiocal Monitoring Devices
- Multi-Parameter Monitoring Devices
- Others
장치 유형을 기준으로 시장은 심장 모니터링 장치, 혈압 모니터링 장치, 혈당 모니터링 장치, 호흡 모니터링 장치, 신경 모니터링 장치, 다중 매개변수 모니터링 장치 등으로 구분됩니다.
애플리케이션
- 종양학
- 당뇨병
- 심혈관 질환
- 기타
시장은 응용 분야별로 종양학, 당뇨병, 심혈관 질환 및 기타 질환으로 구분됩니다.
최종 사용자
- 병원 기반 환자
- 외래환자
- 홈 헬스케어 환자
최종 사용자를 기준으로 시장은 병원 환자, 외래 환자, 재택 건강 관리 환자로 구분됩니다.
글로벌 원격 환자 모니터링 및 케어 시장 지역 분석/통찰력
글로벌 원격 환자 모니터링 및 치료 시장은 장치 유형, 애플리케이션, 최종 사용자 등 세 가지 주요 부문으로 구분됩니다.
이 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 독일, 프랑스, 영국, 이탈리아, 스페인, 벨기에, 터키, 네덜란드, 러시아, 스위스, 유럽의 기타 국가, 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 아시아 태평양의 기타 국가, 브라질, 아르헨티나, 남미의 기타 국가, 남아프리카 공화국, 사우디 아라비아, UAE, 이집트, 이스라엘, 그리고 중동 및 아프리카의 기타 국가입니다.
북미는 RPM 및 케어에 대한 투자 증가로 인해 글로벌 원격 환자 모니터링 및 케어 시장을 주도할 것으로 예상되며, 이는 시장 성장을 촉진할 것으로 예상됩니다. 미국은 RPM 및 케어 제품의 기술 발전 증가로 인해 북미 지역을 주도할 것으로 예상됩니다. 독일은 신흥 시장의 수요 증가와 확장으로 인해 유럽 지역을 주도할 것으로 예상됩니다. 중국은 첨단 기술 프로세스에 대한 고객 성향이 증가함에 따라 아시아 태평양 지역을 주도할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 글로벌 원격 환자 모니터링 및 치료 시장 점유율 분석
글로벌 원격 환자 모니터링 및 치료 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭과 범위, 응용 프로그램 우세, 제품 유형 수명선 곡선입니다. 제공된 위의 데이터 포인트는 회사가 시장에 집중하는 것과만 관련이 있습니다.
글로벌 원격 환자 모니터링 및 치료 시장에서 활동하는 주요 기업으로는 Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips NV, OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, Withings 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 RUSSIA
9.3.6 SPAIN
9.3.7 TURKEY
9.3.8 SWITZERLAND
9.3.9 NETHERLANDS
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 AUSTRALIA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 MALAYSIA
9.4.8 THAILAND
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 REST OF SOUTH AMERICA
9.6 MIDDLE EAST AND AFRICA
9.6.1 SOUTH AFRICA
9.6.2 EGYPT
9.6.3 ISRAEL
9.6.4 UAE
9.6.5 SAUDI ARABIA
9.6.6 REST OF MIDDLE EAST AND AFRICA
10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
표 목록
TABLE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 32 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 U.S. CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 35 U.S. HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 U.S. AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 U.S. HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 39 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 CANADA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 41 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 CANADA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 CANADA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 CANADA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 46 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 MEXICO CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 48 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 MEXICO HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 MEXICO AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 51 MEXICO HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 52 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 53 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 EUROPE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 56 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 EUROPE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 59 EUROPE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 60 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 61 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 62 GERMANY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 63 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 64 GERMANY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 65 GERMANY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 66 GERMANY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 U.K CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 U.K HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 72 U.K AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.K HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 74 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 75 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 FRANCE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 78 FRANCE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 79 FRANCE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 80 FRANCE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 81 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 83 ITALY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 ITALY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 86 ITALY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 87 ITALY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 88 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 89 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 RUSSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 94 RUSSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 95 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 96 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 97 SPAIN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 98 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 99 SPAIN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 100 SPAIN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 101 SPAIN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 102 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 103 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 TURKEY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 TURKEY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 107 TURKEY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 108 TURKEY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 109 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 110 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 SWITZERLAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 112 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 113 SWITZERLAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 114 SWITZERLAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 115 SWITZERLAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 116 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 117 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 NETHERLANDS CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 121 NETHERLANDS AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 122 NETHERLANDS HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 123 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 124 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 125 BELGIUM CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 126 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 127 BELGIUM HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 128 BELGIUM AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 129 BELGIUM HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 130 REST OF EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 139 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 140 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 CHINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 143 CHINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 144 CHINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 145 CHINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 146 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 147 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 JAPAN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 150 JAPAN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 151 JAPAN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 152 JAPAN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 153 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 154 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 AUSTRALIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 AUSTRALIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 158 AUSTRALIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 159 AUSTRALIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 160 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 161 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 INDIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 164 INDIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 165 INDIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 166 INDIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 167 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 168 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 SOUTH KOREA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 SOUTH KOREA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 172 SOUTH KOREA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 173 SOUTH KOREA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 179 SINGAPORE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 180 SINGAPORE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 181 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 182 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 MALAYSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 186 MALAYSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 187 MALAYSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 188 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 THAILAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 191 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 THAILAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 193 THAILAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 194 THAILAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 195 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 196 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 197 INDONESIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 198 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 199 INDONESIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 200 INDONESIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 201 INDONESIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 202 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 203 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 204 PHILIPPINES CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 205 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 PHILIPPINES HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 207 PHILIPPINES AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 208 PHILIPPINES HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 210 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 211 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 212 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 SOUTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 215 SOUTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 216 SOUTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 217 SOUTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 218 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 219 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 220 BRAZIL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 221 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 BRAZIL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 223 BRAZIL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 224 BRAZIL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 225 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 226 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 ARGENTINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 ARGENTINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 230 ARGENTINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 231 ARGENTINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 232 REST OF SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 234 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 235 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 241 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 242 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 SOUTH AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 SOUTH AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 246 SOUTH AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 247 SOUTH AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 248 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 249 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 EGYPT CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 EGYPT HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 253 EGYPT AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 254 EGYPT HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 255 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 256 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 257 ISRAEL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 258 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ISRAEL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 260 ISRAEL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 261 ISRAEL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 262 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 263 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 UAE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 265 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 266 UAE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 267 UAE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 268 UAE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 269 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 270 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 271 SAUDI ARABIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 272 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 273 SAUDI ARABIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 274 SAUDI ARABIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 275 SAUDI ARABIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 276 REST OF MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 EUROPE IS THE FASTEST-GROWING MARKET FOR THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 16 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 17 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 19 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 21 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 23 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 25 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 27 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 29 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022)
FIGURE 30 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2023 & 2030)
FIGURE 31 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022 & 2030)
FIGURE 32 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE (2023-2030)
FIGURE 33 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 34 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 35 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 36 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 37 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 38 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 43 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: SNAPSHOT (2022)
FIGURE 44 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022)
FIGURE 45 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 46 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 47 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: DEVICE TYPE (2023-2030)
FIGURE 48 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 49 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 50 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 51 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 52 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 53 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 54 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 55 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 56 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 57 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 58 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 59 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 60 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 61 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
